Cargando…

Effects of telmisartan and losartan treatments on bone turnover markers in patients with newly diagnosed stage I hypertension

INTRODUCTION: Telmisartan is an angiotensin-II receptor type-1 blocker and a partial agonist for peroxisome proliferator-activated receptor-γ. The aim of this study was to determine the potential effects of telmisartan on bone metabolism and turnover markers. METHODS: Forty-two patients with newly d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aydoğan, Berna İ, Erarslan, Emrah, Ünlütürk, Uğur, Güllü, Sevim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647217/ https://www.ncbi.nlm.nih.gov/pubmed/31328615 http://dx.doi.org/10.1177/1470320319862741

Ejemplares similares

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
por: Vitale, Cristiana, et al.
Publicado: (2005)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)

Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study
por: Kalikar, Mrunalini, et al.
Publicado: (2017)

Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
por: Aydoğan, Berna İmge, et al.
Publicado: (2022)

Cervical Paraganglioma Mimicking Thyroid Nodule: A Rare Clinical Case
por: Aydoğan, Berna İmge, et al.
Publicado: (2016)

Blood pressure-lowering effect of telmisartan compared to losartan among mild to moderate essential hypertensive adult subjects: A meta-analysis
por: Kumari, Kusum, et al.
Publicado: (2022)

Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model
por: Graus-Nunes, Francielle, et al.
Publicado: (2019)

Risk of myocardial infarction, heart failure, and cerebrovascular disease with the use of valsartan, losartan, irbesartan, and telmisartan in patients
por: Yoo, Yung-Geun, et al.
Publicado: (2023)

Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease
por: Brito, Victor Gustavo Balera, et al.
Publicado: (2020)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
por: Liu, Chang-Yuan, et al.
Publicado: (2019)

Telmisartan, when compared to losartan, shows additional beneficial effects to pancreatic islet structure and function in diet-induced obese mice
por: Graus-Nunes, Francielle, et al.
Publicado: (2015)

Hypothyroidism, new nodule formation and increase in nodule size in patients who have undergone hemithyroidectomy
por: Ertek, Sibel, et al.
Publicado: (2012)

Efficacy and Safety of Azilsartan and Telmisartan in Hypertensive Patients
por: Kumar, Alok, et al.
Publicado: (2021)

Corrigendum: Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease
por: Brito, Victor Gustavo Balera, et al.
Publicado: (2021)

Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19
por: Rothlin, Rodolfo Pedro, et al.
Publicado: (2023)

Serum Calprotectin Level as an Inflammatory Marker in Newly Diagnosed Hypertensive Patients
por: Bayrakci, Nergiz, et al.
Publicado: (2022)

Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
por: Mulinari-Santos, Gabriel, et al.
Publicado: (2019)

A Comparative Study of the Management of Stage 2 hypertension by Combined therapy with Losartan, Amlodipine and Hydrochlorothiazide
por: Jafarzadeh Esfehani, Reza, et al.
Publicado: (2012)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
por: Keković, Goran, et al.
Publicado: (2012)

Telmisartan and cardioprotection
por: Akhrass, Philippe R, et al.
Publicado: (2011)

Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension
por: Segura, Julian, et al.
Publicado: (2011)

New standards in hypertension and cardiovascular risk management: focus on telmisartan
por: Galzerano, Domenico, et al.
Publicado: (2010)

Clinical data analysis of telmisartan for hypertension management in Indian population
por: Prem Kumar, A, et al.
Publicado: (2021)

Elevated Urinary T Helper 1 Chemokine Levels in Newly Diagnosed Hypertensive Obese Children
por: Övünç Hacıhamdioğlu, Duygu, et al.
Publicado: (2015)

Bone turnover markers in the early stage of rapidly progressive osteoarthritis of the hip
por: Yasuda, Tadashi, et al.
Publicado: (2021)

Diuretics are Similar to Losartan on Echocardiographic Target-Organ Damage in Stage I Hypertension. PREVER-Treatment Study
por: Bertoluci, Carolina, et al.
Publicado: (2019)

Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study
por: Higaki, Jitsuo, et al.
Publicado: (2016)

Circulating markers of bone turnover
por: Vervloet, Marc G., et al.
Publicado: (2017)

Health-care costs of losartan and candesartan in the primary treatment of hypertension
por: Henriksson, M, et al.
Publicado: (2011)

Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats.
por: Park, C. G., et al.
Publicado: (2001)

Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
por: Bharati, Sandesh Madhukar, et al.
Publicado: (2016)

Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
por: Rakesh, K. B., et al.
Publicado: (2016)

The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia
por: Wu, Liting, et al.
Publicado: (2021)

Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension
por: Akbar Nekooeian, Ali, et al.
Publicado: (2021)

Does Losartan reduce the severity of COVID-19 in hypertensive patients?
por: Mirjalili, Mohammadreza, et al.
Publicado: (2022)

Hypertension and microalbuminuria in HIV infected patients: beneficial effects of the treatment with telmisartan
por: Ucciferri, Claudio, et al.
Publicado: (2010)

The Effect of Telmisartan on Endothelial Function and Arterial Stiffness in Patients With Essential Hypertension
por: Jung, An Doc, et al.
Publicado: (2009)

Low Bone Turnover Associates With Lower Insulin Sensitivity in Newly Diagnosed Drug-Naïve Persons With Type 2 Diabetes
por: Nasser, Mohamad I, et al.
Publicado: (2023)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_afhl1qceivsi6fo2183q8mb13b